Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Guolin Ye
Observed names:
GUOLIN YE,
Guo-Lin Ye,
Guo-lin YE,
Guo-lin Ye
Institution:
First People's Hospital of Foshan
Observed institutions:
Sun Yat-sen University,
Peking University,
First People's Hospital of Foshan,
Peking University People's Hospital
ORCID:
0000-0003-4709-641X
Observed ORCID:
0000-0003-4709-641X
OpenAlex ID:
A5103055098
T3/T4 thoracic sympathictomy and compensatory sweating in treatment of palmar hyperhidrosis
2007
·
Jie YANG
, Jia-ju TAN
, et al.
·
Chinese Medical Journal
·
49
Multifactor artificial intelligence model assists axillary lymph node surgery in breast cancer after neoadjuvant chemotherapy: multicenter retrospective cohort study
2023
·
Teng Zhu
, Yu-Hong Huang
, et al.
·
International Journal of Surgery
·
44
Treatment and Outcome of 341 Papillary Breast Lesions
2019
·
Peixian Chen
, Dan Zhou
, et al.
·
World Journal of Surgery
·
41
PDF
Noninvasive Artificial Intelligence System for Early Predicting Residual Cancer Burden During Neoadjuvant Chemotherapy in Breast Cancer
2024
·
Wei Li
, Yu-Hong Huang
, et al.
·
Annals of Surgery
·
33
Neoadjuvant Taxane Plus Trastuzumab and Pertuzumab With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The Randomized Noninferiority Phase III neoCARHP Trial
2026
·
Hong-Fei Gao
, Guo-Lin Ye
, et al.
·
Journal of Clinical Oncology
·
30
PDF
Expression of pigment epithelium-derived factor is associated with a good prognosis and is correlated with epithelial-mesenchymal transition-related genes in infiltrating ductal breast carcinoma
2015
·
DAN ZHOU
, MIN ZHANG
, et al.
·
Oncology Letters
·
24
PDF
A non-invasive artificial intelligence model for identifying axillary pathological complete response to neoadjuvant chemotherapy in breast cancer: a secondary analysis to multicenter clinical trial
2024
·
Teng Zhu
, Yu-Hong Huang
, et al.
·
British Journal of Cancer
·
16
PDF
Comprehending the cuproptosis and cancer-immunity cycle network: delving into the immune landscape and its predictive role in breast cancer immunotherapy responses and clinical endpoints
2024
·
Xiangwei Liu
, Feng Xu
, et al.
·
Frontiers in Immunology
·
6
PDF
Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study
2022
·
Yunfang Yu
, Huangming Hong
, et al.
·
Cancer Research and Treatment
·
6
PDF
Research on DCE-MRI Images Based on Deep Transfer Learning in Breast Cancer Adjuvant Curative Effect Prediction
2022
·
Guolin Ye
, Suqun He
, et al.
·
Journal of Healthcare Engineering
·
5
PDF
Dynamic changes in intrinsic subtype, immunity status, and risk score before and after neoadjuvant chemo- and HER2-targeted therapy without pCR in HER2-positive breast cancers: A cross-sectional analysis
2022
·
Peixian Chen
, Xiaofan Mao
, et al.
·
Medicine
·
3
Development and validation of a nomogram in survival prediction among advanced breast cancer patients
2020
·
Jianli Zhao
, Yaping Yang
, et al.
·
Annals of Translational Medicine
·
3
PDF
Multiparametric MRI-based longitudinal-radiomics analysis for early prediction of treatment response of breast cancers to neoadjuvant chemotherapy
2025
·
Wei Li
, Yuhong Huang
, et al.
·
Applied Radiation and Isotopes
·
2
Characterizing the 70-gene MammaPrint risk stratification in Chinese luminal type breast cancer and its correlation with clinicopathological characteristics, immune and metabolic functions.
2024
·
Ruilin Pan
, Jiawei Lin
, et al.
·
Journal of Clinical Oncology
PDF
An MRI-based multi-parameter clinical decision support system (NeoMDSS) for early prediction of pathological complete response after the first cycle of neoadjuvant therapy in breast cancer: A multi-center prospective observational cohort study.
2024
·
Liulu Zhang
, Zhaowen Zhu
, et al.
·
Journal of Clinical Oncology
PDF
Longitudinal MRI-Based Radiomic Model Assists Sentinel Lymph Node Biopsy to Reduce False Negative Rate after Neoadjuvant Chemotherapy in Initially Clinically Node-Positive Breast Cancer: A Multicentre, Diagnostic Study
2023
·
Teng Zhu
, Yu-Hong Huang
, et al.
·
SSRN Electronic Journal
Longitudinal Radiomics of Multiparametric MRI to Predict the Risk of Axillary Sentinel Lymph Nodes (SLNs) and Non-SLNs after Neoadjuvant Chemotherapy in Breast Cancer: A Multicenter Study
2022
·
Teng Zhu
, Yu-Hong Huang
, et al.
·
SSRN Electronic Journal
The Comparison of Breast Cancer in Southern China and America: a Multicentre Study in China Versus SEER Database
2021
·
Yingjie Niu
, Fan Zhang
, et al.
·
Research Square
The Comparison of Breast Cancer in Southern China and America: A Multicentre Study in China Versus SEER Database
2021
·
Yingjie Niu
, Fan Zhang
, et al.
·
Research Square
PDF
The Characteristics Comparison of Breast Cancer Patients in Southern China and America: A Multicentre Study in China Versus SEER Database
2020
·
Yingjie Niu
, Fan Zhang
, et al.
PDF
Different maintenance strategies versus observation in patients with hormone receptor-positive metastatic breast cancer after first-line chemotherapy: A real-world study and meta-analysis.
2019
·
Huangming Hong
, Ying Wang
, et al.
·
Journal of Clinical Oncology
Evaluation of FUDR and 5-Fu in neoadjuvant chemotherapy regimen in breast cancer
2012
·
Guolin Ye
·
Chinese Journal of Clinical Oncology and Rehabilitation
Application of sapylin during operation of esophageal carcinoma
2009
·
Guolin Ye
·
Chinese Journal of Clinical Oncology and Rehabilitation
Experience of treatment for foreign body in median esophagus of 43 cases
2008
·
Guolin Ye
·
China Practical Medicine
[Intercostal video-mediastinoscopy: a report of 701 cases].
2007
·
Jie Yang
, Jia-ju Tan
, et al.
·
PubMed
Show more works
View as search
Works count:
27
Citation count:
262
H-index:
7
I10-index:
7
Year
Topic
Type